1 / 12

Overview of the 2013 Cancer Clinical Investigator Team Leadership Award Announcement

Overview of the 2013 Cancer Clinical Investigator Team Leadership Award Announcement. February 5, 2013 Jennifer Hayes, PhD Coordinating Center for Clinical Trials Office of the Director, NCI. Award Purpose. Overall Purpose:

weylin
Download Presentation

Overview of the 2013 Cancer Clinical Investigator Team Leadership Award Announcement

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Overview of the 2013 Cancer Clinical Investigator Team Leadership Award Announcement February 5, 2013 Jennifer Hayes, PhD Coordinating Center for Clinical Trials Office of the Director, NCI

  2. Award Purpose Overall Purpose: • Support outstanding clinical investigators whose participation and activities promote a culture of successful clinical research. • Mid-level clinical investigators at NCI-designated Cancer Centers • At least 3 years but no more than 10 years from initial post-fellowship instructor-level/academic appointment. • Participating in NCI-funded collaborative clinical trials • Promote the retention of clinical investigators in academic clinical research careers.

  3. Funding • Maximum $50,000 total costs per year • Two years • Allowable costs • Salary • Travel (up to $2500/year) • Registration fees for courses, seminars, conferences, workshops • Non-allowable costs • Research-related costs, including but not limited to research supplies, computers, equipment, core facility fees, or sample or data analysis • Salary for personnel other than the nominee • Secretarial or administrative assistance and supplies

  4. Nominee • Nominated by Cancer Center Director • One nominee/application/cancer center • Nominee cannot have received this award previously • Cancer Centers that received the first year of this award in fall 2012 not eligible to submit an application for 2013

  5. Eligibility • Full-time faculty member, assistant or associate professor level • Physician, oncology nurse, clinical psychologist, or similarly qualified clinician with a doctoral degree • Board certified, practicing at least 3 but no more than 10 years from initial academic appointment • Engaged in NCI-funded cancer clinical trials • Must not currently serve or have previously served  as • PI of an NIH R, K, P, U, T, DP, RC, SC or TU series grant • Exceptions: career development awards, mentored awards where the PI is required to be mentored by another investigator • Project leader/co-leader of a research project within a P01/U19 (Program Project Grant/Research Program Cooperative Agreement) • Project leader/co-leader of a research project within a P50 (SPORE) or other P series grant

  6. Narrative • Training, experience, activities • Involvement in NCI-funded cancer clinical trials and clinical trial-related activities • Plans for a career in academic clinical research

  7. Planned Activities and Projects • Outline and describe activities and projects planned under this award, including timeline • Should not propose a specific research project

  8. Letters of Support • Three signed letters of support • At least one institutional support letter should indicate the institution’s level of commitment to fostering the nominee’s career as a clinical investigator in an academic clinical research career, as reflected by the extent to which the nominee will have dedicated time for activities proposed in the application. • At least 15% effort for activities proposed in the application • Include name and institutional affiliations of the individuals who will provide letters of support in the LOI due February 22

  9. Evaluation Criteria • Training and experience • Leadership experience in clinical research activities/clinical trials • Extent and breadth of participation in clinical research activities/clinical trials

  10. Evaluation Criteria cont. • Activities that would not be possible without the award • How award will promote/enhance a successful clinical research culture • Retention of the nominee in an academic clinical research career • Clear institutional commitment to allow at least 15% effort for activities proposed in the application

  11. Timeline February 22, 2013 - Letter of Intent to apply for this administrative supplement due by email • Name of the Cancer Center, intent to apply, Nominee, name and institutional affiliations of individuals who will provide letters of support  March 22, 2013 - Cover Letter, Application, and Letters of Support due • Email an electronic copy of the application in PDF format, including the cover letter and letters of support Late Summer – Notifications sent CCITLA supplements must cycle with the Cancer Center parent P30 award. Award will start on the anniversary date for Cancer Center grants. http://cancercenters.cancer.gov/grants_funding/index.html

  12. HHS logos 12

More Related